MTCH2 and non-small cell lung carcinoma: The results demonstrated a significant reduction in MTCH2 mRNA expression in these NSCLC cells treated with shMTCH2-S1 (Fig. 4H), with MTCH1 mRNA levels remaining unaffected (Fig. 4I).